Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Grant or award Director acquired 13,923 shares (grant or award)
  2. 4 Grant or award Director acquired 13,923 shares (grant or award)
  3. 4 Grant or award Director acquired 13,923 shares (grant or award)
  4. 4 Grant or award Director acquired 13,923 shares (grant or award)
  5. 4 Grant or award Director acquired 13,923 shares (grant or award)
  6. 4 Shares withheld for taxes Ronsheim Matthew gave up 268 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Accounting Officer gave up 976 shares (to pay taxes)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Chief Financial Officer acquired 12,096 shares (grant or award)
  10. 4 Grant or award Ronsheim Matthew acquired 12,768 shares (grant or award)
  11. 4 Grant or award Chief Accounting Officer acquired 10,752 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Shares withheld for taxes Ronsheim Matthew gave up 807 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Accounting Officer gave up 2,862 shares (to pay taxes)
  15. 4 Shares withheld for taxes Ronsheim Matthew gave up 1,600 shares (to pay taxes)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Shares withheld for taxes Chief Accounting Officer gave up 784 shares (to pay taxes)
  18. 4 Open-market sale Chief Accounting Officer sold 10,994 shares at an average $13.99 ($153,810)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 3 of 39 · 776 filings